Holger Rosenbrock

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in CNS Disorders. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Rosenbrock. Retrieved from https://idiyas.com/inventor/holger-rosenbrock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

14 out of 1,564

Boehringer Ingelheim International Gmbh

patents

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

Cognitive Impairment

Anti-TrkB Antibodies

CNS Disorders

PDE9A Modulators

Pyrazolopyrimidinones

GlyT1 Inhibition

Medicinal Compounds

Thiane Derivatives

Phenyl-Methanones

Heterocyclic Derivatives

Cycloalkyl Compounds

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12059408 - Treatment of cognitive impairment associated with schizophrenia (2024-08-13),

2. 11866501 - Anti-TrkB antibodies (2024-01-09),

3. 10919898 - Medical use of compound III (2021-02-16),

4. 10793634 - Anti-TrkB antibodies (2020-10-06),

5. 9328120 - 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders (2016-05-03),

6. 9233953 - Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1 (2016-01-12),

7. 9102679 - Compounds for the treatment of CNS disorders (2015-08-11),

8. 9096603 - 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A modulators (2015-08-04),

9. 9079905 - Compounds for the treatment of CNS disorders (2015-07-14),

10. 9012489 - Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament (2015-04-21),

11. 8912201 - 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders (2014-12-16),

12. 8648085 - 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders (2014-02-11),

13. 8623901 - Compounds for the treatment of CNS disorders (2014-01-07),

14. 8623879 - 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators (2014-01-07),

Title: The Innovative Mind of Holger Rosenbrock

Introduction: Holger Rosenbrock, a talented inventor hailing from Mittelbiberach, Germany, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Holger Rosenbrock's latest patents include cutting-edge advancements in renewable energy technology, smart home systems, and sustainable transportation solutions.

Career Highlights: With a career spanning over two decades, Holger Rosenbrock has established himself as a visionary in the tech industry. His innovative creations have revolutionized various sectors, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Holger Rosenbrock has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the development of groundbreaking technologies.

Conclusion: Holger Rosenbrock's passion for innovation and his relentless drive to push the boundaries of what is possible have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of innovation.

Profile summary based on public USPTO records.